Precision Oncology and Genomically Guided Radiation Therapy

A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference

William A. Hall, Carmen Bergom, Reid Thompson, Andrew M. Baschnagel, Srinivasan Vijayakumar, Henning Willers, X. Allen Li, Christopher J. Schultz, George D. Wilson, Catharine M.L. West, Jacek Capala, C. Norman Coleman, Javier F. Torres-Roca, Joanne Weidhaas, Felix Y. Feng

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose: To summarize important talking points from a 2016 symposium focusing on real-world challenges to advancing precision medicine in radiation oncology, and to help radiation oncologists navigate the practical challenges of precision, radiation oncology. Methods and Materials: The American Society for Radiation Oncology, American Association of Physicists in Medicine, and National Cancer Institute cosponsored a meeting on precision medicine in radiation oncology. In June 2016 numerous scientists, clinicians, and physicists convened at the National Institutes of Health to discuss challenges and future directions toward personalized radiation therapy. Various breakout sessions were held to discuss particular components and approaches to the implementation of personalized radiation oncology. This article summarizes the genomically guided radiation therapy breakout session. Results: A summary of existing genomic data enabling personalized radiation therapy, ongoing clinical trials, current challenges, and future directions was collected. The group attempted to provide both a current overview of data that radiation oncologists could use to personalize therapy, along with data that are anticipated in the coming years. It seems apparent from the provided review that a considerable opportunity exists to truly bring genomically guided radiation therapy into clinical reality. Conclusions: Genomically guided radiation therapy is a necessity that must be embraced in the coming years. Incorporating these data into treatment recommendations will provide radiation oncologists with a substantial opportunity to improve outcomes for numerous cancer patients. More research focused on this topic is needed to bring genomic signatures into routine standard of care.

Original languageEnglish (US)
Pages (from-to)274-284
Number of pages11
JournalInternational Journal of Radiation Oncology Biology Physics
Volume101
Issue number2
DOIs
StatePublished - Jun 1 2018

Fingerprint

Precision Medicine
Radiation Oncology
National Cancer Institute (U.S.)
medicine
radiation therapy
Radiotherapy
cancer
Medicine
radiation
National Institutes of Health (U.S.)
Standard of Care
talking
Clinical Trials
recommendations
health
therapy
Therapeutics
Research
signatures
Radiation Oncologists

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Precision Oncology and Genomically Guided Radiation Therapy : A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. / Hall, William A.; Bergom, Carmen; Thompson, Reid; Baschnagel, Andrew M.; Vijayakumar, Srinivasan; Willers, Henning; Li, X. Allen; Schultz, Christopher J.; Wilson, George D.; West, Catharine M.L.; Capala, Jacek; Coleman, C. Norman; Torres-Roca, Javier F.; Weidhaas, Joanne; Feng, Felix Y.

In: International Journal of Radiation Oncology Biology Physics, Vol. 101, No. 2, 01.06.2018, p. 274-284.

Research output: Contribution to journalArticle

Hall, William A. ; Bergom, Carmen ; Thompson, Reid ; Baschnagel, Andrew M. ; Vijayakumar, Srinivasan ; Willers, Henning ; Li, X. Allen ; Schultz, Christopher J. ; Wilson, George D. ; West, Catharine M.L. ; Capala, Jacek ; Coleman, C. Norman ; Torres-Roca, Javier F. ; Weidhaas, Joanne ; Feng, Felix Y. / Precision Oncology and Genomically Guided Radiation Therapy : A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. In: International Journal of Radiation Oncology Biology Physics. 2018 ; Vol. 101, No. 2. pp. 274-284.
@article{1e9a79172ce44914bcb95f2168b10873,
title = "Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference",
abstract = "Purpose: To summarize important talking points from a 2016 symposium focusing on real-world challenges to advancing precision medicine in radiation oncology, and to help radiation oncologists navigate the practical challenges of precision, radiation oncology. Methods and Materials: The American Society for Radiation Oncology, American Association of Physicists in Medicine, and National Cancer Institute cosponsored a meeting on precision medicine in radiation oncology. In June 2016 numerous scientists, clinicians, and physicists convened at the National Institutes of Health to discuss challenges and future directions toward personalized radiation therapy. Various breakout sessions were held to discuss particular components and approaches to the implementation of personalized radiation oncology. This article summarizes the genomically guided radiation therapy breakout session. Results: A summary of existing genomic data enabling personalized radiation therapy, ongoing clinical trials, current challenges, and future directions was collected. The group attempted to provide both a current overview of data that radiation oncologists could use to personalize therapy, along with data that are anticipated in the coming years. It seems apparent from the provided review that a considerable opportunity exists to truly bring genomically guided radiation therapy into clinical reality. Conclusions: Genomically guided radiation therapy is a necessity that must be embraced in the coming years. Incorporating these data into treatment recommendations will provide radiation oncologists with a substantial opportunity to improve outcomes for numerous cancer patients. More research focused on this topic is needed to bring genomic signatures into routine standard of care.",
author = "Hall, {William A.} and Carmen Bergom and Reid Thompson and Baschnagel, {Andrew M.} and Srinivasan Vijayakumar and Henning Willers and Li, {X. Allen} and Schultz, {Christopher J.} and Wilson, {George D.} and West, {Catharine M.L.} and Jacek Capala and Coleman, {C. Norman} and Torres-Roca, {Javier F.} and Joanne Weidhaas and Feng, {Felix Y.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.ijrobp.2017.05.044",
language = "English (US)",
volume = "101",
pages = "274--284",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Precision Oncology and Genomically Guided Radiation Therapy

T2 - A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference

AU - Hall, William A.

AU - Bergom, Carmen

AU - Thompson, Reid

AU - Baschnagel, Andrew M.

AU - Vijayakumar, Srinivasan

AU - Willers, Henning

AU - Li, X. Allen

AU - Schultz, Christopher J.

AU - Wilson, George D.

AU - West, Catharine M.L.

AU - Capala, Jacek

AU - Coleman, C. Norman

AU - Torres-Roca, Javier F.

AU - Weidhaas, Joanne

AU - Feng, Felix Y.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Purpose: To summarize important talking points from a 2016 symposium focusing on real-world challenges to advancing precision medicine in radiation oncology, and to help radiation oncologists navigate the practical challenges of precision, radiation oncology. Methods and Materials: The American Society for Radiation Oncology, American Association of Physicists in Medicine, and National Cancer Institute cosponsored a meeting on precision medicine in radiation oncology. In June 2016 numerous scientists, clinicians, and physicists convened at the National Institutes of Health to discuss challenges and future directions toward personalized radiation therapy. Various breakout sessions were held to discuss particular components and approaches to the implementation of personalized radiation oncology. This article summarizes the genomically guided radiation therapy breakout session. Results: A summary of existing genomic data enabling personalized radiation therapy, ongoing clinical trials, current challenges, and future directions was collected. The group attempted to provide both a current overview of data that radiation oncologists could use to personalize therapy, along with data that are anticipated in the coming years. It seems apparent from the provided review that a considerable opportunity exists to truly bring genomically guided radiation therapy into clinical reality. Conclusions: Genomically guided radiation therapy is a necessity that must be embraced in the coming years. Incorporating these data into treatment recommendations will provide radiation oncologists with a substantial opportunity to improve outcomes for numerous cancer patients. More research focused on this topic is needed to bring genomic signatures into routine standard of care.

AB - Purpose: To summarize important talking points from a 2016 symposium focusing on real-world challenges to advancing precision medicine in radiation oncology, and to help radiation oncologists navigate the practical challenges of precision, radiation oncology. Methods and Materials: The American Society for Radiation Oncology, American Association of Physicists in Medicine, and National Cancer Institute cosponsored a meeting on precision medicine in radiation oncology. In June 2016 numerous scientists, clinicians, and physicists convened at the National Institutes of Health to discuss challenges and future directions toward personalized radiation therapy. Various breakout sessions were held to discuss particular components and approaches to the implementation of personalized radiation oncology. This article summarizes the genomically guided radiation therapy breakout session. Results: A summary of existing genomic data enabling personalized radiation therapy, ongoing clinical trials, current challenges, and future directions was collected. The group attempted to provide both a current overview of data that radiation oncologists could use to personalize therapy, along with data that are anticipated in the coming years. It seems apparent from the provided review that a considerable opportunity exists to truly bring genomically guided radiation therapy into clinical reality. Conclusions: Genomically guided radiation therapy is a necessity that must be embraced in the coming years. Incorporating these data into treatment recommendations will provide radiation oncologists with a substantial opportunity to improve outcomes for numerous cancer patients. More research focused on this topic is needed to bring genomic signatures into routine standard of care.

UR - http://www.scopus.com/inward/record.url?scp=85030158569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030158569&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2017.05.044

DO - 10.1016/j.ijrobp.2017.05.044

M3 - Article

VL - 101

SP - 274

EP - 284

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -